Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta‐Epidemiological Analysis

Cancer Medicine(2025)10.1002/cam4.71097Source: DataRank Database

Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta‐Epidemiological Analysis is a research paper published in Cancer Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.41)OA: goldTopics (47)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Pavlos Msaouel ORCID,Avital M. Miller ORCID,Ramez Kouzy ORCID,Timothy A. Lin ORCID,Joseph Abi Jaoude ORCID

Live enrichment

PubMed:40879280 PMC:PMC12313818 OpenAlex:https://openalex.org/W4412817124

National Cancer Institute

Grant: P30CA016672

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

Andrew Sabin Family Foundation

FWCI

1.41

Citation Percentile

0.8%

Citation Trend

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.71097

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.71097

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.71097

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.71097

journalhttps://doi.org/10.1002/cam4.71097

Fields of Study

Statistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesMeta-analysis and systematic reviews03 medical and health sciences0302 clinical medicineHumansClinical Trials, Phase III as TopicRandomized Controlled Trials as TopicDouble-Blind MethodNeoplasmsMedical OncologyProgression-Free SurvivalResearch DesignPhysicians

MeSH Terms

Progression-Free SurvivalDouble-Blind MethodHumansMedical OncologyNeoplasmsPhysiciansResearch DesignRandomized Controlled Trials as TopicClinical Trials, Phase III as Topic

Keywords

BlindingMedicineClinical endpointClinical trialInternal medicineOdds ratioRandomized controlled trialSurrogate endpointMeta-analysisOncologyBiasRandomized TrialsPhase IiiBlinded Independent Central ReviewDouble‐blindClinical Trials, Phase III as TopicDouble-Blind MethodResearch DesignNeoplasmsPhysiciansHumansMedical OncologyProgression-Free SurvivalRandomized Controlled Trials as Topic